IFN-producing killer dendritic cells contribute to the inhibitory effect of poly I:C on the progression of murine melanoma

Journal of Immunotherapy

Volumn 31, Issue 6, 2008, Pages 555-562

  Jiang, Qun ^a   Wei, Haiming ^a   Tian, Zhigang ^a,b  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

IFN ; IKDCs; Immunotherapy; Murine melanoma; Poly I:C

Indexed keywords

CD45 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN P 15095; POLYINOSINIC POLYCYTIDYLIC ACID; KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY B; KILLER CELL LECTIN-LIKE RECEPTOR SUBFAMILY B; LECTIN; MEMBRANE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER PREVENTION; CANCER SURVIVAL; CELL EXPANSION; CONTROLLED STUDY; CYTOLYSIS; DENDRITIC CELL; DRUG CYTOTOXICITY; EX VIVO STUDY; IN VITRO STUDY; IN VIVO STUDY; INTERFERON PRODUCTION; KILLER CELL; LIVER; LIVER METASTASIS; LUNG; LUNG METASTASIS; MALE; MELANOMA; MELANOMA B16; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; EXPERIMENTAL MELANOMA; FEMALE; IMMUNOLOGY;

ANIMALS; ANTIGENS, CD11C; ANTIGENS, CD45; ANTIGENS, SURFACE; DENDRITIC CELLS; FEMALE; INTERFERON TYPE II; KILLER CELLS, NATURAL; LECTINS, C-TYPE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; POLY I-C;

EID: 48549092219     PISSN: 15249557     EISSN: None     Source Type: Journal    
DOI: 10.1097/CJI.0b013e31817d8e75     Document Type: Article

References (32)

1. Cella M, Salio M, Sakakibara Y, et al. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J Exp Med. 1999;189:821-829.
2. Khan AL, Heys SD, Eremin O. Synthetic polyribonucleotides: current role and potential use in oncological practice. Eur J Surg Oncol. 1995;21:224-227.
3. Seya T, Akazawa T, Uehori J, et al. Role of toll-like receptors and their adaptors in adjuvant immunotherapy for cancer. Anticancer Res. 2003;23:4369-4376.
4. Akazawa T, Ebihara T, Okuno M, et al. Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cells. Proc Natl Acad Sci USA. 2007;104:252-257.
5. Fujimura T, Nakagawa S, Ohtani T, et al. Inhibitory effect of the polyinosinic-polycytidylic acid/cationic liposome on the progression of murine B16F10 melanoma. Eur J Immunol. 2006;36:3371-3380.
6. Schroder K, Hertzog PJ, Ravasi T, et al. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol. 2004;75:163-189.
7. Shankaran V, Ikeda H, Bruce AT, et al. IFN gamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature. 2001;410:1107-1111.
8. Street SE, Cretney E, Smyth MJ. Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis. Blood. 2001;97:192-197.
9. Grundy MA, Zhang T, Sentman CL. NK cells rapidly remove B16F10 tumor cells in a perforin and interferon-gamma independent manner in vivo. Cancer Immunol Immunother. 2007;56:1153-1561.
10. Taieb J, Chaput N, Menard C, et al. A novel dendritic cell subset involved in tumor immunosurveillance. Nat Med. 2006;12:214-249.
11. Chan CW, Crafton E, Fan HN, et al. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat Med. 2006;12:207-213.
12. Vremec D, O'Keeffe M, Hochrein H, et al. Production of interferons by dendritic cells, plasmacytoid cells, natural killer cells, and interferon-producing killer dendritic cells. Blood. 2007;109:1165-1173.
13. Vosshenrich CA, Lesjean-Pottier S, Hasan M, et al. CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells. J Exp Med. 2007;204:2569-2578.
14. Caminschi I, Ahmet F, Heger K, et al. Putative IKDCs are functionally and developmentally similar to natural killer cells, but not to dendritic cells. J Exp Med. 2007;204:2579-2590.
15. Blasius AL, Barchet W, Cella M, et al. Development and function of murine B220+CD11c+NK1.1+ cells identify them as a subset of NK cells. J Exp Med. 2007;204:2561-2568.
16. Bonmort M, Ullrich E, Mignot G, et al. Interferon-gamma is produced by another player of innate immune responses: the interferon-producing killer dendritic cell (IKDC). Biochimie. 2007;89:872-877.
17. Holt PG, Degebrodt A, Venaille T, et al. Preparation of interstitial lung cells by enzymatic digestion of tissue slices: preliminary characterization by morphology and performance in functional assays. Immunology. 1985;54:139-147.
18. Kelly JM, Darcy PK, Markby JL, et al. Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection. Nat Immunol. 2002;3:83-90.
19. Ramakrishna V, Vasilakos JP, Tario JD, et al. Toll-like receptor activation enhances cell-mediated immunity induced by an antibody vaccine targeting human dendritic cells. J Transl Med. 2007;5:5.
20. Cui Z, Qiu F. Synthetic double-stranded RNA poly(I:C) as a potent peptide vaccine adjuvant: therapeutic activity against human cervical cancer in a rodent model. Cancer Immunol Immunother. 2006;55:1267-1279.
21. Fernandez NC, Lozier A, Flament C, et al. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med. 1999;5:405-411.
22. Puddu P, Fantuzzi L, Borghi P, et al. IL-12 induces IFN-gamma expression and secretion in mouse peritoneal macrophages. J Immunol. 1997;159:3490-3497.
23. Lorsbach RB, Murphy WJ, Lowenstein CJ, et al. Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between interferongamma and lipopolysaccharide. J Biol Chem. 1993;268:1908-1913.
24. Nguyen KB, Watford WT, Salomon R, et al. Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection. Science. 2002;297:2063-2066.
25. Berenson LS, Gavrieli M, Farrar JD, et al. Distinct characteristics of murine STAT4 activation in response to IL-12 and IFN-alpha. J Immunol. 2006;177:5195-5203.
26. Wang J, Pham-Mitchell N, Schindler C, et al. Dysregulated Sonic hedgehog signaling and medulloblastoma consequent to IFN-alphastimulated STAT2-independent production of IFN-gamma in the brain. J Clin Invest. 2003;112:535-543.
27. Freudenberg MA, Merlin T, Kalis C, et al. Cutting edge: a murine, IL-12-independent pathway of IFN-gamma induction by Gramnegative bacteria based on STAT4 activation by Type I IFN and IL-18 signaling. J Immunol. 2002;169:1665-1668.
28. Hamerman JA, Ogasawara K, Lanier LL. NK cells in innate immunity. Curr Opin Immunol. 2005;17:29-35.
29. Chaudhry UI, Kingham TP, Plitas G, et al. Combined stimulation with interleukin-18 and CpG induces murine natural killer dendritic cells to produce IFN-gamma and inhibit tumor growth. Cancer Res. 2006;66:10497-10504.
30. Santini SM, Lapenta C, Logozzi M, et al. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J Exp Med. 2000;191:1777-1788.
31. Chaudhry UI, Plitas G, Burt BM, et al. NK dendritic cells expanded in IL-15 exhibit antitumor responses in vivo. J Immunol. 2007; 179:4654-4660.
32. Arina A, Murillo O, Dubrot J, et al. Interleukin-15 liver gene transfer increases the number and function of IKDCs and NK cells. Gene Ther. 2008;15:473-483.